You have 9 free searches left this month | to do more

trc105

Trc105 is a drug used to treat Glioblastoma Multiforme, Prostate Cancer, Advanced Angiosarcoma, and other conditions. Trc105 is being actively studied in 1 study and prior, has been studied in 9.

Top SponsorsTop SitesTop Investigators
Tracon Pharmaceuticals Inc.National Institutes of Health Clinical Center, 9000 Rockville PikeAndrea Apolo, M.D.
National Cancer Institute (NCI)Ohio State UniversityEdwin Posadas, MD
University of Alabama at BirminghamCleveland ClinicErica Stringer-Reasor
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
2022-01-24
Jan 24, 2022
T
No longer available
  • Solid Tumors
  • TRC105
  • +4 more
  • Santa Monica, California
    UCLA
2021-01-28
Jan 28, 2021
U
Completed
  • Lung Cancer
  • TRC105
  • Birmingham, Alabama
    UAB Comprehensive Cancer Center
2021-06-24
Jun 24, 2021
C
Completed
  • Prostate Cancer
  • TRC105
  • +2 more
  • Los Angeles, California
    Cedars Sinai Medical Center
2020-12-04
Dec 4, 2020
T
Completed
  • Non Small Cell Lung Cancer
  • TRC105
  • (no location specified)
2019-10-04
Oct 4, 2019
T
Terminated
  • Gestational Trophoblastic Neoplasia
  • +3 more
  • Boston, Massachusetts
  • +2 more
2019-07-09
Jul 9, 2019
T
Completed
  • Advanced Angiosarcoma
  • Tucson, Arizona
  • +38 more
2020-05-11
May 11, 2020
T
Completed
  • Glioblastoma
  • Glioblastoma Multiforme
  • Cincinnati, Ohio
  • +3 more
2019-05-21
May 21, 2019
T
Completed
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +1 more
2019-02-28
Feb 28, 2019
N
Completed
  • Prostate Cancer
  • Metastatic Castrate Resistant Prostate Cancer
  • TRC105
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2018-04-13
Apr 13, 2018
N
Completed
  • Hepatocellular Carcinoma
  • +2 more
  • TRC105
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2017-06-29
Jun 29, 2017
N
Completed
  • Urothelial Carcinoma
  • +4 more
  • TRC105
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2016-11-16
Nov 16, 2016
N
Terminated
  • Glioblastoma Multiforme
  • TRC105
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2015-10-06
Oct 6, 2015